Meeder Asset Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-73
Closed -$2K 2272
2019
Q2
$2K Hold
73
﹤0.01% 1883
2019
Q1
$3K Buy
73
+8
+12% +$329 ﹤0.01% 1512
2018
Q4
$3K Buy
65
+15
+30% +$692 ﹤0.01% 1528
2018
Q3
$4K Buy
50
+30
+150% +$2.4K ﹤0.01% 1378
2018
Q2
$1.91K Buy
20
+11
+122% +$1.05K ﹤0.01% 1423
2018
Q1
$1K Buy
+9
New +$1K ﹤0.01% 1483